Atlas Trials

Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis

Clinical trial NCT04485546 · COMPLETED

Trial details

NCT number
NCT04485546
Sponsor
Dompé Farmaceutici S.p.A
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Neurotrophic Keratitis
Start date
2020-09-09
Primary completion
2021-09-30
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.